Treatment with Paclitaxel Orotate and Carboxyamidotriazole Orotate in SC-Implanted OVCAR-5 Human Ovarian Tumor Xenografts

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"Treatment with Paclitaxel Orotate and Carboxyamidotriazole Orotate in SC-Implanted OVCAR-5 Human Ovarian Tumor Xenografts"
written by Rashida A. Karmali, Yulia Maxuitenko, Greg Gorman,
published by Journal of Cancer Therapy, Vol.4 No.4, 2013

has been cited by the following article(s):

[1]	Co-delivery of paclitaxel and indocyanine green by PEGylated graphene oxide: a potential integrated nanoplatform for tumor theranostics
	RSC Advances, 2016

[2]	Emerging therapies for glioblastoma
	JAMA neurology, 2014

[3]	Comparative Response of SC CAKI-1 Renal Tumor to Treatment with Doxorubicin HCl and Doxorubicin Orotate
	Journal of Cancer Therapy, 2014

[1]	Co-delivery of paclitaxel and indocyanine green by PEGylated graphene oxide: a potential integrated nanoplatform for tumor theranostics RSC Adv., 2016 DOI:10.1039/C5RA25518J

[2]	Effect of Carboxyamidotriazole Orotate, a Modulator of Calcium-Dependent Signaling Pathways, on Advanced Solid Tumors Journal of Cancer Therapy, 2015 DOI:10.4236/jct.2015.64035

[3]	Comparative Response of SC CAKI-1 Renal Tumor to Treatment with Doxorubicin HCl and Doxorubicin Orotate Journal of Cancer Therapy, 2014 DOI:10.4236/jct.2014.55049

Follow SCIRP